Joan McCormick

Principal, Price Regulation Consulting

With more than 25 years of experience in the operation of the Canadian pharmaceutical market, Joan assists major pharmaceutical companies in developing their pricing strategy and preparing submissions to the Patented Medicine Prices Review Board (PMPRB).  Based in Ottawa, she leads the Price Regulation Consulting team for IQVIA,  providing in-depth analysis, expert advice, and foundational training on the PMPRB’s processes and policies.

Joan obtained her bachelor’s degree in Life Sciences from Queen’s University in Kingston, and her Masters in Business Administration from the University of Ottawa.

All Sessions by Joan McCormick

Printer Friendly See Full Agenda

Day 1: Feb 26, 2020

5:00 pm

5:00 pm

New PMPRB Regulations: Impact on industry, marketing and digital

In August 2019, the Patented Medicines Pricing Review Board (PMPRB) amended Regulations that will have a significant impact on the future of Canadian pharmaceutical companies, Canada’s life sciences sector and ultimately patients.  The amended Regulations will drop drug ceiling prices by up to 70%, which will create a significant dis-incentive for future investment.

This talk will discuss how these changes will impact the pharma industry after they go into effect on July 1st 2020 including:

  • The potential impact on current products and future drug launches
  • The impact to customers, including payers, physicians and patients
  • The impact on marketing as we strive for customer-centric solutions and to be a valued partner in healthcare

Understand how the new PMPRB regulations will impact the pharma industry and how companies will need to adapt and transform

Day 2: Feb 27, 2020